Cardiac Ultrasound Systems Market: The Sonographer Constraint, Handheld Dilution, and Catheter Consumables

Growth ran near 6.4% from 2020 to 2025, held back at the start by deferred hospital capital and pulled forward later by point-of-care adoption that the same period accelerated sharply. Handheld and compact devices sold in volumes nobody had forecast, while cart replacement stalled and then recovered unevenly. Chinese manufacturers took meaningful cardiac share from the established four across Asia and beyond.
Base case growth of 7.4% rests on three mechanisms operating largely independently of each other. Structural heart and electrophysiology procedure volumes keep rising, and each procedure now consumes imaging catheters rather than merely occupying a scanner. Artificial intelligence guidance lets less experienced operators acquire diagnostic images, which partially relieves the staffing constraint. And replacement demand from a large installed base resumes as deferred capital cycles finally close. None of the three depends on the others arriving first.
The bull case at 8.6% assumes intracardiac imaging becomes standard practice in atrial fibrillation ablation, converting a capital market into a consumables one across a large procedure population. The bear case at 6.2% is a staffing failure: vacancies worsen faster than guidance software compensates, scan volumes fall short of referral demand, and hospitals defer replacement because utilisation never justifies it.